Cumberland Pharmaceuticals
CPIX
23 hedge funds and large institutions have $7.43M invested in Cumberland Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 6 closing their positions.
0.93% less ownership
Funds ownership: 19.53% → 18.6% (-0.93%)
18% less funds holding
Funds holding: 28 → 23 (-5)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
83% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 6
85% less capital inflows, than outflows
Capital inflows: $90K | Capital outflows: $594K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$35.7K |
| 2 |
Bridgeway Capital Management
Houston,
Texas
|
+$22.6K |
| 3 |
Berkshire Asset Management
Wilkes Barre,
Pennsylvania
|
+$15.9K |
| 4 |
Tower Research Capital (TRC)
New York
|
+$11.4K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$4.36K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$187K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$175K |
| 3 |
Renaissance Technologies
New York
|
-$110K |
| 4 |
Ariel Investments
Chicago,
Illinois
|
-$34K |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$30K |
CPIX Hedge Fund Activity: Q3 2021 in Review
23 of the 5,730 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q3 2021, worth a combined $7.43M — down 11% from $8.36M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of CPIX and 1 opened new positions — a net loss of 5 holders — while 7 trimmed existing stakes and 5 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $35.7K. The largest seller was BlackRock, cutting an estimated $187K.
- 23 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q3 2021, down from 28 in Q2 2021.
- Funds reported $7.43M of Cumberland Pharmaceuticals stock for Q3 2021, down 11% quarter-over-quarter.
- 1 fund opened new Cumberland Pharmaceuticals positions in Q3 2021 and 6 closed out, a net change of -5 holders.
- The largest Cumberland Pharmaceuticals buyer in Q3 2021 was Citadel Advisors, an estimated $35.7K added.
- The largest Cumberland Pharmaceuticals seller in Q3 2021 was BlackRock, an estimated $187K sold.
Based on aggregated 13F filings for Q3 2021.